| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
In prospective studies of acute uncomplicated, multidrug-resistant falciparum malaria on the western border of Thailand, the oral artemisinin derivatives were used alone in the treatment of 836 patients (artesunate 630, artemether 206), were combined with mefloquine (15-25 mg base/kg) in 2,826 patients, and mefloquine alone was used in 1,303 patients. The combined regimens of mefloquine plus an artemisinin derivative were associated with more side effects than those with an artemisinin derivative alone; acute nausea (31% versus 16%), vomiting (24% versus 11%), anorexia (51% versus 34%), and dizziness (47% versus 15%) (P < 0.001). Oral artesunate and artemether alone were very well tolerated. There was no difference in the incidence of possible adverse effects between the two drugs, and no evidence that either derivative caused allergic reactions, neurologic or psychiatric reactions, or cardiovascular or dermatologic toxicity. Blackwater fever occurred in three patients treated with mefloquine plus artesunate regimens. Oral artesunate and artemether are safe and well tolerated antimalarial drugs.
This article has been cited by other articles:
|
|
 |
|
  Hepatitis Temporally Associated With an Herbal Supplement Containing Artemisinin--Washington, 2008 JAMA, October 7, 2009; 302(13): 1412 - 1414. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Maude, K. Plewes, M. A. Faiz, J. Hanson, P. Charunwatthana, S. J. Lee, J. Tarning, E. B. Yunus, M. G. Hoque, M. U. Hasan, et al. Does Artesunate Prolong the Electrocardiograph QT Interval in Patients with Severe Malaria? Am J Trop Med Hyg, January 1, 2009; 80(1): 126 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Rosenthal Artesunate for the Treatment of Severe Falciparum Malaria N. Engl. J. Med., April 24, 2008; 358(17): 1829 - 1836. [Full Text] [PDF]
|
|
|
|
|
|
F. Nosten and N. J. White Artemisinin-Based Combination Treatment of Falciparum Malaria Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 181 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Thapa, J. Hollander, M. Linehan, J. Cox-Singh, M. B. Bista, G. D. Thakur, W. A. Davis, and T. M. E. Davis Comparison of Artemether-Lumefantrine with Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria in Eastern Nepal Am J Trop Med Hyg, September 1, 2007; 77(3): 423 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Lamikanra, D. Brown, A. Potocnik, C. Casals-Pascual, J. Langhorne, and D. J. Roberts Malarial anemia: of mice and men Blood, July 1, 2007; 110(1): 18 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Karunajeewa, L. Manning, I. Mueller, K. F. Ilett, and T. M. E. Davis Rectal Administration of Artemisinin Derivatives for the Treatment of Malaria JAMA, June 6, 2007; 297(21): 2381 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Griffith, L. S. Lewis, S. Mali, and M. E. Parise Treatment of Malaria in the United States: A Systematic Review JAMA, May 23, 2007; 297(20): 2264 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. HUTAGALUNG, H. HTOO, P. NWEE, J. ARUNKAMOMKIRI, J. ZWANG, V. I. CARRARA, E. ASHLEY, P. SINGHASIVANON, N. J. WHITE, and F. NOSTEN A CASE-CONTROL AUDITORY EVALUATION OF PATIENTS TREATED WITH ARTEMETHER-LUMEFANTRINE Am J Trop Med Hyg, February 1, 2006; 74(2): 211 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bell and P. Winstanley Current issues in the treatment of uncomplicated malaria in Africa Br. Med. Bull., December 13, 2004; 71(1): 29 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. BERGQUIST, J. UTZINGER, J. CHOLLET, X. SHU-HUA, N. A. WEISS, and M. TANNER TRIGGERING OF HIGH-LEVEL RESISTANCE AGAINST SCHISTOSOMA MANSONI REINFECTION BY ARTEMETHER IN THE MOUSE MODEL Am J Trop Med Hyg, December 1, 2004; 71(6): 774 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Utzinger, J. Keiser, X. Shuhua, M. Tanner, and B. H. Singer Combination Chemotherapy of Schistosomiasis in Laboratory Studies and Clinical Trials Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1487 - 1495. [Full Text] [PDF]
|
|
|
|
|
|
G. Schmuck, E. Roehrdanz, R. K. Haynes, and R. Kahl Neurotoxic Mode of Action of Artemisinin Antimicrob. Agents Chemother., March 1, 2002; 46(3): 821 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Weatherall, L. H. Miller, D. I. Baruch, K. Marsh, O. K. Doumbo, C. Casals-Pascual, and D. J. Roberts Malaria and the Red Cell Hematology, January 1, 2002; 2002(1): 35 - 57. [Abstract] [Full Text]
|
|
|
|
 |
|
 Seeking New Approaches to Resistant Malaria Journal Watch Infectious Diseases, July 1, 1999; 1999(701): 5 - 5. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
